Skip to content

Remel R24640

by Remel, Inc.

Ref R24640

Remel R24640 is a clostridium difficile antigen IVD (EU IVDD general IVD; FDA Class I; FDA product code LLH, Reagents, Clostridium Difficile Toxin) made by Remel, Inc., registered in EUDAMED on 29 Sep 2026 (Basic UDI-DI B-00848838068416), cleared under FDA 510(k) K041951 on 15 Nov 2004 and listed in FDA GUDID since 21 Apr 2022 (UDI-DI 00848838068416), active as of 25 Oct 2026.

Active European Union and United States. Also listed in GUDID (US).

CE IVDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 25 Oct 2026

Documents

None, self-declared

Class I: no certifier involved

510(k) K041951

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 25 Oct 2026.

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-00848838068416 Basic UDI-DI 00848838068416UDI-DIDate29 Sep 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00848838068416 UDI-DI Date21 Apr 2022ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK041951 Date15 Nov 2004DecidedStatusActive

Official records

From the FDA record

Device description
Xpect C. diff Toxin A/B KT/40TST
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 25 Oct 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-00848838068416 registered 29 Sep 2026 Active
  • FDA 510(k) K041951 decided 15 Nov 2004 Active
  • FDA GUDID UDI-DI 00848838068416 listed 21 Apr 2022 Listed

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Timeline

3 dated events

  1. Cleared FDA 510(k) K041951
  2. Listed FDA GUDID 00848838068416
  3. Registered EUDAMED B-00848838068416

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Xpect C. Diff Toxin a/B Kt/40TST EUDAMED
Remel GUDID
Generic name
Clostridium difficile antigen IVD, kit, rapid ICT, clinical
Device name
Xpect C. Diff Toxin a/B
Model / reference
R24640
Primary DI / UDI-DI
00848838068416
Basic UDI-DI
B-00848838068416
510(k) Number
FDA product code
LLH
EMDN code
W0105011802 C.difficile toxin a/b detection
GMDN term
Clostridium difficile antigen IVD, kit, rapid ICT, clinical
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
866.2660
EU registration type
Legacy device (under a directive)
EU market of registration
Netherlands
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class I

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under C.DIFFICILE TOXIN A/B DETECTION.

Other devices from Remel, Inc.

See all devices from Remel, Inc. →

Properties

  • Single use
  • Contains animal tissues or cells
  • Contains substances of microbial origin
  • Reagent
  • IVD kit
  • Professional testing
  • IVD instrument
  • Lot / batch number
  • Expiration date
Other properties (16, all answered No)